医学
吉西他滨
内科学
肿瘤科
临床研究阶段
化疗
毒性
耐受性
不利影响
癌症研究
药理学
中性粒细胞减少症
癌症
养生
临床试验
粘膜炎
胰腺癌
作者
Udai Banerji,Elizabeth Ruth Plummer,Victor Moreno,Joo Ern Ang,Amy Quinton,Yvette Drew,Tatiana Hernandez,Desamparados Roda,Louise Carter,Alejandro Navarro,Rebecca Kristeleit,Hendrik-Tobias Arkenau,Debashis Sarker,Daniel Castellano,Harriet S. Walter,Patricia Roxburgh,Sarah P. Blagden,Alan Anthoney,Ines Verdon,Robert H. Jones
标识
DOI：10.1200/jco.2019.37.15_suppl.3095
摘要
3095Background: SRA737 is a potent, highly selective and orally-bioavailable inhibitor of checkpoint kinase 1 (Chk1). SRA737-02 was designed to investigate the safety, tolerability and preliminary ...
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
淡然的熊猫
back you up
昏睡的蟠桃
bc
平常的毛豆
lin
HEIKU
ZhouYW
iNk
冰魂
SYLH
科研小民工
Ankher
余味
孤独尔白
Auston_zhong
Leo
爱静静
Mercury
皖公网安备34019202002308
